IgA nephropathy: open trials in Israel

• NCT04557462

  A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Ashkelon · Jerusalem · Petah Tikva

  Registry updated 2026-10-05

• NCT06994845

  Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN

  Trial Treatment · Phase 3 · Novartis Pharmaceuticals

  Beersheba · Haifa · Jerusalem · Petah Tikva

  Registry updated 2026-09-09

• NCT06797518

  Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN

  Trial Treatment · Phase 2 · Novartis Pharmaceuticals

  Ashdod · Hadera · Haifa · Nahariya

  Registry updated 2026-07-29

All IgA nephropathy trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error